Novo Nordisk received European Commission approval for a weight-loss pill version of Wegovy and a ready-to-use 7.2 mg pen.
FirstSquawk07/15, 10:51 PM
Related assets
Coming up for NVO
Explore next
Latest NVO news
MarketWatch08/27, 03:37 PM
Deutsche Bank downgraded Novo Nordisk to sell after the stock fell 70% from its peak.
Jin1008/27, 10:33 AM
Novo Nordisk has applied for approval of an oral formulation of Wegovy for weight management.
Finnhub08/19, 05:10 PM